BCDDP Follow Up To Cost $1.6 Million annually For Five Years Okayed; Limited To 59,000 Women
In Brief: NCAB to Hear Report On Treatment Programs, Discuss Hogness Plan For New Type of Review
Clinical Oncology Programs Extended Two Years; No Decision Yet On Further Expansion
NCI T Phase Out Support Of VA Lung Group, But Will Continue Funding VASAG
Three New RFAs Announced In Cancer Control
Trending Stories
- “Backwater to Blockbuster” chronicles the previously untold story of the explosive growth of St. Jude Children’s Research Hospital
In a conversation with Deborah Doroshow, co-authors Chuck Sherr and Bill Evans discuss their collaborative writing process - DOJ alleges that Yale and UCLA discriminated based on race in medical school admissions
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- How City of Hope is turning microbiome science into better cancer care
- FDA clears fruit-flavored vapes, relaxes enforcement on black-market products with pending premarket applications
Critics say policies clear the way for major tobacco companies to enter fruit-flavored vape market









